Jose E. Rodriguez-Martinez
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: August 21, 2025
Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome.
Journal: Frontiers in immunology
Published: August 05, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 10, 2025
Ongoing phase 2 agents for multiple sclerosis: could we break the phase 3 trial deadlock?
Journal: Expert opinion on investigational drugs
Published: February 25, 2025
Efficacy of cognitive rehabilitation in cognition and brain networks: A randomised clinical trial in patients with multiple sclerosis.
Journal: NeuroImage. Clinical
Published: November 19, 2024
Very late-onset neuromyelitis optica, a report of two cases.
Journal: Archivos de la Sociedad Espanola de Oftalmologia
Published: October 27, 2024
Economic burden of secondary progressive multiple sclerosis: DISCOVER study.
Journal: BMC health services research
Published: April 02, 2024
Decreased exercise-induced natural killer cell redistribution in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: January 04, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.
Journal: Brain : a journal of neurology
Published: December 23, 2023
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study.
Journal: Multiple sclerosis and related disorders
Published: September 19, 2023
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
Journal: JAMA neurology
Published: February 27, 2023
Last Updated: 09/26/2026